Progressive cardiac conduction disease

Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention

Volumn , Issue , 2008, Pages 564-576

  Schott, Jean Jacques ^a   Charpentier, Flavien ^a   Marec, Hervé Le ^a  

^a L INSTITUT DU THORAX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84877043976     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84628-854-8_39     Document Type: Chapter

References (61)

1. Michaelsson M, Jonzon A, Riesenfeld T. Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation 1995;92(3):442-449.
2. Balmer C, Fasnacht M, Rahn M, et al. Long-term follow up of children with congenital complete atrioventricular block and the impact of pacemaker therapy. Europace 2002;4(4):345-349.
3. Tan HL, Bezzina CR, Smits JP, Verkerk AO, Wilde AA. Genetic control of sodium channel function. Cardiovasc Res 2003;57(4):961-973.
4. Roden DM, Balser JR, George AL Jr, et al. Cardiac ion channels. Annu Rev Physiol 2002;64:431-475.
5. Roden DM, George AL Jr. Structure and function of cardiac sodium and potassium channels. Am J Physiol 1997;273(2 Pt 2):H511-525.
6. Benson DW. Genetics of atrioventricular conduction disease in humans. Anat Rec A Discov Mol Cell Evol Biol 2004;280(2):934-939 (review).
7. Lenegre J. The pathology of complete atrioventricular block. Prog Cardiovasc Dis 1964;6:317-323.
8. Lev M, Kinare SG, Pick A. The pathogenesis of complete atrioventricular block. Prog Cardiovasc Dis 1964;6:317-326.
9. Morgagni GB. De sedibus, et causis morborum per anatomen indagatis libri quinque. 2 volumes. In 1. Venetis, typ. Remondiniana 1761.
10. Adams R. Cases of disease of the heart, accompanied with pathological observation. Dublin Hosp Rep 1827;4:353-453.
11. Stokes W. Observations on some cases of permanently slow pulse. Q J Med Sci 1846;2:73-85.
12. Van Den Heuvel G C J. Die ziekte van Stokres-Adams en een geval van aangeborne hart blok. Groningen, 1908.
13. Lev M, Kinare SG, Pick A. The pathogenesis of atrioventricular block in coronary disease. Circulation 197;42:409-425.
14. Bharati S, Lev M, Dhingra RC, et al. Electrophysiologic and pathologic correlations in two cases of chronic second degree atrioventricular block with left bundle branch block. Circulation 1975;52(2):221-229.
15. Lev M, Cuadros H, Paul MH. Interruption of the atrioventricular bundle with congenital atrioventricular block. Circulation 1971;43(5):703-710.
16. Morquio L. Sur une maladie infantile et familiale caracterisee par des modifications permanentes du pouls, des attaques syncopales et epileptiformes et la mort subite. Arch Med Enfants 1901;4:467-475.
17. Osler W. On the so-called Stokes-Adams disease. Lancet II 1903;516-524.
18. Fulton Z M K, Judson, CF, Norris GW. Congenital heart block occurring in a father and two children, one an infant. Am J Med Sci 1910;140:339-348.
19. Wallgren A, Winblad S. Congenital heart-block. Acta Paediatr 1937;20:175-204.
20. Wendkos MH. Familial congenital complete A-V heart blocks. Am Heart J 1947;34:138-142.
21. Gazes PC, Culler RM, Taber E, et al. Congenital familial cardiac conduction defects. Circulation 1965;32:32-34.
22. Combrink J M D, Davis WH, Snyman HW. Familial bundle branch block. Am Heart J 1962;64:397-400.
23. Steenkamp WF. Familial trifascicular block. Am Heart J 1972;84:758-760.
24. Brink AJ, Torrington M. Progressive familial heart block-two types. S Afr Med J 1977;52:53-59.
25. Steenkamp WF. Familial trifascicular block. Am Heart J 1972;84(6):758-760.
26. Van Der Merwe PL, Weymar HW, Torrington M, Brink AJ. Progressive familial heart block. Part II. Clinical and ECG confirmation of progression-report on 4 cases. S Afr Med J 1986;70(6):356-357.
27. Van Der Merwe PL, Weymar HW, Torrington M, Brink AJ. Progressive familial heart block (type I). A follow-up study after 10 years. S Afr Med J 1988;73:275-276.
28. Stephan E. Hereditary bundle branch system defect: Survey of a family with four affected generations. Am Heart J 1978;95:89-95.
29. Stephan E, De Meeus A, Bouvagnet P. Hereditary bundle branch defect: Right bundle branch blocks of different causes have different morphologic characteristics. Am Heart J 1997;133:249-256.
30. Brink PA, Ferreira A, Moolman JC, et al. Gene for progressive familial heart block type I maps to chromosome 19q13. Circulation 1995;91:1633-1640.
31. De Meeus A, Stephan E, Debrus S, Jean MK, Loiselet J, Weissenbach J, Demaille J, Bouvagnet P. An isolated cardiac conduction disease maps to chromosome 19q. Circ Res 1995;77(4):735-740.
32. Schott JJ, Alshinawi C, Kyndt F, et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 1999;23:20-21.
33. Probst V, Kyndt F, Potet F, et al. Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenegre disease. J Am Coll Cardiol 2003;41(4):643-652.
34. Van Veen TA, Stein M, Royer A, et al. Impaired impulse propagation in Scn5a-knockout mice: Combined contribution of excitability, connexin expression, and tissue architecture in relation to aging. Circulation 2005;112(13):1927- 1935.
35. Royer A, Van Veen TA, Le Bouter S, et al. Mouse model of SCN5A-linked hereditary Lenegre's disease: Age-related conduction slowing and myocardial fibrosis. Circulation 2005;111(14):1738-1746.
36. Herfst LJ, Potet F, Bezzina CR, et al. Na+ channel mutation leading to loss of function and nonprogressive cardiac conduction defects. J Mol Cell Cardiol 2003;35(5):549-557.
37. Tan HL, Bink-Boelkens MT, Bezzina CR, et al. A sodium-channel mutation causes isolated cardiac conduction disease. Nature 2001;409:1043-1047.
38. Wang DW, Viswanathan PC, Balser JR, et al. Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation 2002;105:341-346.
39. Bezzina CR, Rook MB, Groenewegen WA, et al. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res 2003;92:159-168.
40. Niu DM, Hwang B, Hwang HW, et al. A common SCN5A polymorphism attenuates a severe cardiac phenotype caused by a non-sense SCN5A mutation in a Chinese family with an inherited cardiac conduction defect. J Med Genet 2006;43(10):817-821.
41. Viswanathan PC, Benson DW, Balser JR. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Invest 2003;111(3):341-346.
42. Groenewegen WA, Firouzi M, Bezzina CR, et al. A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res 2003;92(1):14-22.
43. Makita N, Sasaki K, Groenewegen WA, et al. Congenital atrial standstill associated with coinheritance of a novel SCN5A mutation and connexin 40 polymorphisms. Heart Rhythm 2005;2(10):1128-1134.
44. McNair WP, Ku L, Taylor MR, et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 2004;110(15):2163-2167.
45. Olson TM, Michels VV, Ballew JD, et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 2005;293(4):447-454.
46. Laitinen-Forsblom PJ, Makynen P, Makynen H, et al. SCN5A mutation associated with cardiac conduction defect and atrial arrhythmias. J Cardiovasc Electrophysiol 2006;17(5):480-485.
47. Hanson EL, Jakobs PM, Keegan H, et al. Cardiac troponin T lysine 210 deletion in a family with dilated cardiomyopathy. J Card Fail 2002;8:28-32.
48. Oropeza ES, Cadena CN. New phenotype of familial dilated cardiomyopathy and conduction disorders. Am Heart J 2003;145:317-323.
49. Schott JJ, Benson DW, Basson CT, et al. Congenital heart disease caused by mutations in the transcription factor NKX2.5. Science 1998;281:108-111.
50. McElhinney DB, Geiger E, Blinder J, Benson DW, Goldmuntz E. NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol 2003;42(9):1650-1655.
51. Kanada M, Demirtas M, Guzel R, et al. Cardiomyopathy and atrioventricular block in Emery-Dreifuss muscular dystrophy-a case report. Angiology 2002;53:109-112.
52. Graber HL, Unverferth DV, Baker PB, et al. Evolution of a hereditary cardiac conduction and muscle disorder: A study involving a family with six generations affected. Circulation 1986;74:21-35.
53. Ohkubo R, Nakagawa M, Higuchi I, et al. Familial skeletal myopathy with atrioventricular block. Intern Med 1999;38:856-860.
54. Gollob MH, Green MS, Tang AS, et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 2001;344(24):1823- 1831.
55. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-1396.
56. Priori SG, Napolitano C, Gasparini M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation 2000;102:2509-2515.
57. Kyndt F, Probst V, Potet F, et al. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation 2001;104:3081-3086.
58. Smits JP, Eckardt L, Probst V, et al. Genotypephenotype relationship in Brugada syndrome: Electrocardiographic features differentiate SCN5Arelated patients from non-SCN5A-related patients. J Am Coll Cardiol 2002;40:350-356.
59. Shimizu W, Antzelevitch C, Suyama K, et al. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2000;11:1320-1329.
60. Probst V, Allouis M, Sacher F, et al. Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation. J Cardiovasc Electrophysiol 2006;17(3):270-275.
61. Hong K, Brugada J, Oliva A, Berruezo-Sanchez A, et al. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation 2004;110:3023-3027.